Officer and Director Stock Transactions for AVITA Medical, Inc.

Suzanne Crowe, a director at AVITA Medical, Inc., acquired 22,214 shares of Common Stock on January 20, 2026, with a reported transaction price of $0.00, increasing her post-transaction holdings to 69,148 shares. This acquisition is noted as an award of restricted stock units (RSUs) subject to time-based vesting. Additionally, Crowe was granted 16,133 stock options with an exercise price of $3.77 per share, also vesting on January 20, 2026. Both the RSU award and the stock option grant were subject to and received stockholder approval on June 3, 2026. The filing indicates that the reported shares include unvested RSUs and 22,990 Chief Depositary Interests (CDIs), which translate to 4,598 shares of Common Stock.